Partnership to develop inhalable vaccines

shutterstock_65560813.jpg

The Respiratory Technology team at the Woolcock Institute of Medical Research, in collaboration with Evonik Industries, have been awarded an Australian Research Council (ARC) linkage grant to develop a low-cost vaccination platform. The team will develop a new inhalation technology that can be used to deliver a multitude of DNA based vaccines via the inhalation route. This project is very exciting news and marks the start of a new industrial collaboration. The grant, entitled: ‘One for all and all for one- Engineering a drug delivery platform for DNA vaccines to the lung’, was awarded to A/Prof Traini, Young and Dr Windhab and will last for 3 years  The ARC support this grant via $482,738 of funding.